Optimization of Parkinson Disease Treatment Combining Anti-Parkinson Drugs and Deep Brain Stimulation Using Patient Diaries

被引:0
|
作者
Schneider, Jakub [1 ]
Novak, Daniel [1 ]
Jech, Robert [2 ,3 ]
机构
[1] Czech Tech Univ, Fac Elect Engn, Dept Cybernet, Karlovo Namesti 13, CR-16635 Prague 2, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic
来源
2015 37TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC) | 2015年
关键词
LEVODOPA; SLEEP;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The number of patients suffering from Parkinson's disease is increasing rapidly due to population aging. While traditional medications-based palliative therapy is successful in early stages, deep brain stimulation (DBS) may be used as an alternative treatment in later stages. After DBS implantation, the therapy typically consists of electrical stimulation and reduced medication. In order to provide good clinical outcome, a balance has to be found between medication and stimulation parameters, this is usually done as follows: First, Unified Parkinson's Disease Rating Scale (UPDRS) scoring is performed, second patients are supposed to fill subjective diaries during a specific period. This study shows that these diaries are useful as therapy progression indicator. Feel scores based on diaries and sleep time were examined with respect to DBS stimulation and medication. The results confirmed the positive effect of both therapy components stimulation as well as medication -on patient feel scores. Furthermore, a positive correlation was observed between stimulation energy and sleep duration.
引用
收藏
页码:3444 / 3447
页数:4
相关论文
共 50 条
  • [41] Drug Therapy of Patients with Parkinson's Disease after Deep Brain Stimulation
    Timmermann, L.
    AKTUELLE NEUROLOGIE, 2009, 36 : S306 - S311
  • [42] Combined and Sequential Treatment with Deep Brain Stimulation and Continuous Intrajejunal Levodopa Infusion for Parkinson's Disease
    van Poppelen, Daniel
    Tromp, Annelie N. M.
    de Bie, Rob M. A.
    Dijk, Joke M.
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (06):
  • [43] Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease
    Mueller, Karsten
    Jech, Robert
    Ruzicka, Filip
    Holiga, Stefan
    Ballarini, Tommaso
    Bezdicek, Ondrej
    Moeller, Harald E.
    Vymazal, Josef
    Ruzicka, Evzen
    Schroeter, Matthias L.
    Urgosik, Dusan
    NEUROIMAGE-CLINICAL, 2018, 19 : 1025 - 1035
  • [44] Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease
    Charles, David
    Konrad, Peter E.
    Neimat, Joseph S.
    Molinari, Anna L.
    Tramontana, Michael G.
    Finder, Stuart G.
    Gill, Chandler E.
    Bliton, Mark J.
    Kao, Chris
    Phibbs, Fenna T.
    Hedera, Peter
    Salomon, Ronald M.
    Cannard, Kevin R.
    Wang, Lily
    Song, Yanna
    Davis, Thomas L.
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (07) : 731 - 737
  • [45] Initial cognitive dip after subthalamic deep brain stimulation in Parkinson disease
    Han-Joon Kim
    Beom S. Jeon
    Ji Young Yun
    Young Eun Kim
    Hui-Jun Yang
    Sun Ha Paek
    Journal of Neurology, 2013, 260 : 2130 - 2133
  • [46] Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease
    Brodsky, Matthew A.
    Anderson, Shannon
    Murchison, Charles
    Seier, Mara
    Wilhelm, Jennifer
    Vederman, Aaron
    Burchiel, Kim J.
    NEUROLOGY, 2017, 89 (19) : 1944 - 1950
  • [47] In Reply: Modulation of Nigrofugal and Pallidofugal Pathways in Deep Brain Stimulation for Parkinson Disease
    Avecillas-Chasin, Josue M.
    Honey, Christopher R.
    NEUROSURGERY, 2020, 87 (03) : E423 - E424
  • [48] King's Parkinson's Disease Pain Scale for Assessment of Pain Relief Following Deep Brain Stimulation for Parkinson's Disease
    DiMarzio, Marisa
    Pilitsis, Julie G.
    Gee, Lucy
    Peng, Sophia
    Prusik, Julia
    Durphy, Jennifer
    Ramirez-Zamora, Adolfo
    Hanspal, Era
    Molho, Eric
    McCallum, Sarah E.
    NEUROMODULATION, 2018, 21 (06): : 617 - 622
  • [49] Determination of six anti-Parkinson drugs using cyclodextrin-capillary electrophoresis method: application to pharmaceutical dosage forms
    Zeid, Abdallah M.
    Nasr, Jenny Jeehan M.
    Belal, Fathalla F.
    Kitagawa, Shinya
    Kaji, Noritada
    Baba, Yoshinobu
    Walash, Mohamed I.
    RSC ADVANCES, 2016, 6 (21): : 17519 - 17530
  • [50] The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease
    Birchall, Elizabeth L.
    Walker, Harrison C.
    Cutter, Gary
    Guthrie, Stephanie
    Joop, Allen
    Memon, Raima A.
    Watts, Ray L.
    Standaert, David G.
    Amara, Amy W.
    BRAIN STIMULATION, 2017, 10 (03) : 651 - 656